Nucleic acid-based therapeutics, including antisense oligonucleotides (ASO), small interfering RNA (siRNA), messenger RNA (mRNA), immunomodulatory DNA/RNA, and gene-editing guide RNA (gRNA), are promising because they can treat diseases by targeting their genetic information directly in vivo. These treatments can provide long-lasting or even curative effects by inhibiting, adding, replacing, or editing genes.  This technical note […]